NCT01643304已完成不适用
A Swedish Cross-sectional Study With Questionnaire to Investigate Perception of Menstrual Bleeding
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 1,547
- 主要终点
- Prevalence of subjectively experienced heavy menstrual bleeding assessed by questionnaire
研究概览
简要总结
This field based, questionnaire study will document observational data on womens perception of menstrual bleeding in a cross-section of women in Sweden. Each subject will complete the questionnaire at one occasion.
研究设计
- 研究类型
- Observational
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 40 Years 至 45 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •All women 40-45 years available in the web-panel of SIFO
- •Completion of the web-based questionnaire
排除标准
- 未提供
结局指标
主要结局
Prevalence of subjectively experienced heavy menstrual bleeding assessed by questionnaire
时间窗: Once at baseline
次要结局
- Social consequences of heavy menstrual bleedings assessed by questionnaire(Once at baseline)
- Costs; e.g. pads, absence from work, loss of income assessed by questionnaire(Once at baseline)
- The treatments given for heavy menstrual bleedings, as surgery or medication assessed by questionnaire(Once at baseline)
研究者
相似试验
尚未招募
Unknown
A survey study to identify menstrual practice among school childreCTRI/2024/07/070776SDM college of Ayurveda
招募中
不适用
Apple Women's Health StudyMenstrual CycleOvulationMenstruationPolycystic Ovary SyndromeReproductionReproductive HealthInfertilityMenopauseNCT04196595Apple Inc.500,000
已完成
不适用
Perimenopause-Related Mood and Behavioral DisordersMood DisorderNCT00001231National Institute of Mental Health (NIMH)1,158
已完成
不适用
A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line TreatmentBreast CancerNCT06311383Novartis Pharmaceuticals2,610
已完成
不适用
Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in FrancePost Menopausal OsteoporosisNCT02347865Amgen777